Sacubitril intermediate and preparation method thereof

US11370739B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11370739-B2
Application numberUS-201916679154-A
CountryUS
Kind codeB2
Filing dateNov 9, 2019
Priority dateFeb 29, 2016
Publication dateJun 28, 2022
Grant dateJun 28, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention relates to a sacubitril intermediate and a preparation method thereof. The sacubitril intermediate disclosed herein can be prepared by a deprotection reaction of a compound. In addition, the intermediate can be used as a raw material to synthesize sacubitril.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of Formula (V), wherein: R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate; R2 is with the proviso that when R 1 is phenyl, R2 is not R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl; and R 4 is H, —(C 1 -C 4 )alkyl, —(C 3 -C 6 )heterocyclyl, —(C 1 -C 4 )alkyl-aryl, trimethylsilyl, triethylsilyl or t-butyldimethylsilyl. 2. The compound of claim 1 , wherein R 1 is phenyl. 3. The compound of claim 1 , wherein R 3 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl, benzyl or substituted benzyl. 4. The compound of claim 1 , wherein R 4 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl, trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, triphenylmethyl, tetrahydrofuryl, benzyl or substituted benzyl. 5. The compound of claim 1 , wherein R 2 is —COOH, —COOCH 3 , —COOCH 2 CH 3 , —COOCH(CH 3 ) 2 , —COOC(CH 3 ) 3 , —COOCH 2 Ph, —CH 2 OH, —CH 2 OCH 3 , —CH 2 OCH 2 CH 3 , —CH 2 OCH(CH 3 ) 2 , —CH 2 OC(CH 3 ) 3 , —CH 2 OCH 2 Ph, —CH 2 OC(Ph) 3 , —CH 2 OSi(CH 3 ) 3 , —CH 2 OSi(CH 2 CH 3 ) 3 , —CH 2 OSi(CH 3 ) 2 C(CH 3 ) 3 , —CONH 2 , —CONHCH 3 , —CONHCH 2 CH 3 , —CONHCH (CH 3 ) 2 , —CONHC (CH 3 ) 3 , —CONHCH 2 Ph or with the proviso that when R 1 is phenyl, R 2 is —CH 2 OH, —CH 2 OCH 3 , —CH 2 OCH 2 CH 3 , —CH 2 OCH(CH 3 ) 2 , —CH 2 OC(CH 3 ) 3 , —CH 2 OCH 2 Ph, —CH 2 OC(Ph) 3 , —CH 2 OSi(CH 3 ) 3 , —CH 2 OSi(CH 2 CH 3 ) 3 , —CH 2 OSi(CH 3 ) 2 C(CH 3 ) 3 , —CONH 2 , —CONHCH 3 , —CONHCH 2 CH 3 , —CONHCH (CH 3 ) 2 , —CONHC (CH 3 ) 3 , —CONHCH 2 Ph or and wherein each Ph is phenyl. 6. The compound of claim 1 having one of the following structures: where each Ph is phenyl. 7. The compound of claim 1 , wherein R 2 is 8. The compound of claim 7 , wherein R 1 is phenyl. 9. The compound of claim 7 , wherein R 4 is H. 10. The compound of claim 9 , wherein R 1 is phenyl. 11. A method of preparing a compound of Formula (V): wherein the compound of Formula (V) is prepared by a deprotection reaction of a compound of Formula (IV): in the presence of a base or an acid, wherein: R 1 is phenyl, methoxy, hydroxy, chloro, bromo, iodo, mesylate, triflate or 4-methylbenzenesulfonate; R 2 is with the proviso that when R 1 is phenyl, R 2 is not R 3 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl; R 4 is H, —(C 1 -C 4 )alkyl, —(C 3 -C 6 )heterocyclyl, —(C 1 -C 4 )alkyl-aryl, trimethylsilyl, triethylsilyl or t-butyldimethylsilyl; and R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 12. The method of claim 11 , the compound of Formula (IV) is prepared by a substitution reaction of a compound of Formula (II) with a compound of Formula (III) in the presence of a base; 13. The method of claim 12 , the compound of Formula (II) is prepared by a condensation reaction of a compound of Formula (I); wherein R 1 is as defined above; and R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 14. The method according to claim 11 , wherein the compound of the Formula (IV) is prepared by a process comprising the following steps: a) preparing a compound of Formula (II) by a condensation reaction of a compound of Formula (I) in the presence of a base, and b) preparing a compound of Formula (IV) by a substitution reaction of the compound of Formula (II) with a compound of Formula (III) in the presence of a strong base; wherein R 1 is phenyl; R 2 is R 3 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl or benzyl; R 4 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl, t-butyl, benzyl, trimethylsilyl, triethylsilyl, t-butyldimethylsilyl, triphenylmethyl, or tetrahydrofuryl; R 5 is H, methyl, ethyl, n-propyl, i-propyl, n-butyl or benzyl; and R 6 is triflate, mesylate or 4-methylbenzenesulfonate. 15. The method of claim 14 wherein the compound of Formula (II) is prepared by a condensation reaction of the compound of Formula (I) with N,N′-carbonyldiimidazole and a compound of Formula (VIII): in the presence of magnesium chloride and triethylamine, wherein R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl. 16. The method of claim 14 , wherein the compound of Formula (II) is prepared by a condensation reaction of the compound of Formula (I) with Meldrum's acid, 4-dimethylaminopyridine, R 5 OH and pivaloyl chloride in the presence of N,N-diisopropylethylamine, R 5 is H, —(C 1 -C 4 )alkyl or —(C 1 -C 4 )alkyl-aryl.

Assignees

Inventors

Classifications

  • Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids · CPC title

  • Amines; Imines · CPC title

  • by reactions not provided for in C07F7/1876 - C07F7/1888 · CPC title

  • C07F7/1804Primary

    Compounds having Si-O-C linkages (Si-O-acyl linkages C07F7/1896) · CPC title

  • only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11370739B2 cover?
The present invention relates to a sacubitril intermediate and a preparation method thereof. The sacubitril intermediate disclosed herein can be prepared by a deprotection reaction of a compound. In addition, the intermediate can be used as a raw material to synthesize sacubitril.
Who is the assignee on this patent?
North & South Brother Pharmacy Investment Co Ltd, Sunshine Lake Pharma Co Ltd
What technology area does this patent fall under?
Primary CPC classification C07F7/1804. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 28 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).